North America is witnessing steady adoption of expression vectors, supported by an established biotechnology ecosystem, increasing biopharmaceutical research, and growing investments in advanced therapeutic development. The region benefits from extensive research activities in recombinant protein production, gene therapy, vaccine development, and synthetic biology, creating opportunities for...